nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Dexamethasone—atopic dermatitis	0.117	0.206	CbGbCtD
Bosentan—CYP3A4—Pimecrolimus—atopic dermatitis	0.0796	0.141	CbGbCtD
Bosentan—CYP2C9—Loratadine—atopic dermatitis	0.0596	0.105	CbGbCtD
Bosentan—CYP2C9—Diphenhydramine—atopic dermatitis	0.0596	0.105	CbGbCtD
Bosentan—CYP3A4—Tacrolimus—atopic dermatitis	0.0474	0.0838	CbGbCtD
Bosentan—CYP3A4—Loratadine—atopic dermatitis	0.0347	0.0613	CbGbCtD
Bosentan—CYP3A4—Methylprednisolone—atopic dermatitis	0.0317	0.0561	CbGbCtD
Bosentan—CYP3A4—Triamcinolone—atopic dermatitis	0.024	0.0425	CbGbCtD
Bosentan—CYP2C9—Dexamethasone—atopic dermatitis	0.0206	0.0365	CbGbCtD
Bosentan—CYP3A4—Betamethasone—atopic dermatitis	0.0206	0.0365	CbGbCtD
Bosentan—CYP3A4—Prednisolone—atopic dermatitis	0.0203	0.036	CbGbCtD
Bosentan—CYP3A4—Hydrocortisone—atopic dermatitis	0.0193	0.0341	CbGbCtD
Bosentan—CYP3A4—Prednisone—atopic dermatitis	0.0192	0.034	CbGbCtD
Bosentan—CYP3A4—Dexamethasone—atopic dermatitis	0.012	0.0212	CbGbCtD
Bosentan—EDNRB—Peptide GPCRs—CCR3—atopic dermatitis	0.00225	0.0249	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00202	0.0223	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CXCR3—atopic dermatitis	0.00197	0.0218	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.0018	0.0199	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00161	0.0178	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR3—atopic dermatitis	0.00161	0.0178	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00144	0.016	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CXCR3—atopic dermatitis	0.00141	0.0156	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00135	0.015	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.0013	0.0144	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00129	0.0142	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CCR5—atopic dermatitis	0.00123	0.0137	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00121	0.0133	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CXCR3—atopic dermatitis	0.00119	0.0132	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00115	0.0128	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00108	0.012	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00106	0.0117	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL22—atopic dermatitis	0.00103	0.0114	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00102	0.0112	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000968	0.0107	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—NPS—atopic dermatitis	0.000956	0.0106	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000956	0.0106	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000944	0.0104	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000944	0.0104	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00093	0.0103	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000925	0.0102	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL27—atopic dermatitis	0.000918	0.0102	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CCR5—atopic dermatitis	0.000883	0.00977	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000871	0.00964	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000862	0.00954	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000855	0.00946	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000855	0.00946	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000829	0.00917	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL17—atopic dermatitis	0.000823	0.00911	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000774	0.00856	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000758	0.00839	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CCR5—atopic dermatitis	0.000748	0.00828	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000748	0.00828	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—MAPK8—atopic dermatitis	0.000746	0.00826	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL22—atopic dermatitis	0.000737	0.00815	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000725	0.00802	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00071	0.00786	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000684	0.00757	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—NPS—atopic dermatitis	0.000684	0.00757	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000675	0.00747	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000675	0.00747	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL11—atopic dermatitis	0.000663	0.00734	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000662	0.00733	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL27—atopic dermatitis	0.000657	0.00727	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000644	0.00713	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000633	0.007	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000633	0.007	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000624	0.0069	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000621	0.00687	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000612	0.00677	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000612	0.00677	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000593	0.00657	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL17—atopic dermatitis	0.000589	0.00652	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00058	0.00642	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR3—atopic dermatitis	0.000541	0.00598	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000535	0.00592	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—MAPK8—atopic dermatitis	0.000534	0.00591	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL22—atopic dermatitis	0.000528	0.00585	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL27—atopic dermatitis	0.000519	0.00574	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000519	0.00574	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000508	0.00562	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000502	0.00555	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—TAC1—atopic dermatitis	0.000482	0.00533	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—NPS—atopic dermatitis	0.000482	0.00533	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL11—atopic dermatitis	0.000475	0.00525	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCR3—atopic dermatitis	0.000473	0.00523	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL27—atopic dermatitis	0.000471	0.00521	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000461	0.0051	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000454	0.00503	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000453	0.00501	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000453	0.00501	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000444	0.00492	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000432	0.00478	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL17—atopic dermatitis	0.000422	0.00467	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000415	0.00459	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000389	0.00431	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR3—atopic dermatitis	0.000387	0.00428	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL10—atopic dermatitis	0.000382	0.00423	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL22—atopic dermatitis	0.000378	0.00418	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCL27—atopic dermatitis	0.000371	0.00411	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000359	0.00397	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000351	0.00388	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—NPS—atopic dermatitis	0.000345	0.00382	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—TAC1—atopic dermatitis	0.000345	0.00382	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCL11—atopic dermatitis	0.00034	0.00377	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000339	0.00375	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCR3—atopic dermatitis	0.000338	0.00374	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL27—atopic dermatitis	0.000337	0.00373	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FCER2—atopic dermatitis	0.000336	0.00372	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCL5—atopic dermatitis	0.000329	0.00364	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000329	0.00364	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000325	0.0036	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL22—atopic dermatitis	0.000312	0.00345	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000309	0.00342	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCR3—atopic dermatitis	0.000306	0.00338	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL17—atopic dermatitis	0.000302	0.00335	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CCR5—atopic dermatitis	0.000296	0.00328	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000278	0.00308	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL27—atopic dermatitis	0.000278	0.00308	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CCR3—atopic dermatitis	0.000278	0.00307	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL10—atopic dermatitis	0.000273	0.00303	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—NPS—atopic dermatitis	0.000272	0.00301	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—TAC1—atopic dermatitis	0.000272	0.00301	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000267	0.00296	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—IL5—atopic dermatitis	0.000253	0.0028	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000251	0.00278	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL17—atopic dermatitis	0.00025	0.00276	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—TAC1—atopic dermatitis	0.000247	0.00274	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—NPS—atopic dermatitis	0.000247	0.00274	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL11—atopic dermatitis	0.000244	0.0027	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCR3—atopic dermatitis	0.000243	0.00268	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FCER2—atopic dermatitis	0.00024	0.00266	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCL5—atopic dermatitis	0.000235	0.00261	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000235	0.0026	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL5—atopic dermatitis	0.00023	0.00254	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000224	0.00248	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL22—atopic dermatitis	0.000223	0.00247	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—KIF3A—atopic dermatitis	0.000222	0.00246	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CCR3—atopic dermatitis	0.000219	0.00242	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000216	0.00239	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CCR5—atopic dermatitis	0.000212	0.00235	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL11—atopic dermatitis	0.000201	0.00223	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CMA1—atopic dermatitis	0.000201	0.00223	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL27—atopic dermatitis	0.000199	0.0022	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCR3—atopic dermatitis	0.000199	0.0022	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL10—atopic dermatitis	0.000196	0.00217	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—TAC1—atopic dermatitis	0.000195	0.00216	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—NPS—atopic dermatitis	0.000195	0.00216	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000191	0.00212	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT6—atopic dermatitis	0.000189	0.00209	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CCL5—atopic dermatitis	0.000186	0.00206	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—IL5—atopic dermatitis	0.000181	0.00201	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL8—atopic dermatitis	0.000179	0.00198	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL17—atopic dermatitis	0.000179	0.00198	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000178	0.00197	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—NPS—atopic dermatitis	0.000177	0.00196	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—TAC1—atopic dermatitis	0.000177	0.00196	CbGpPWpGaD
Bosentan—Angiopathy—Betamethasone—atopic dermatitis	0.000174	0.000506	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCR3—atopic dermatitis	0.000174	0.00192	CbGpPWpGaD
Bosentan—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000172	0.000499	CcSEcCtD
Bosentan—Bradycardia—Prednisone—atopic dermatitis	0.00017	0.000494	CcSEcCtD
Bosentan—Dizziness—Tacrolimus—atopic dermatitis	0.000169	0.000492	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CCL5—atopic dermatitis	0.000169	0.00187	CbGpPWpGaD
Bosentan—Discomfort—Prednisolone—atopic dermatitis	0.000168	0.000489	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000168	0.00186	CbGpPWpGaD
Bosentan—Angioedema—Triamcinolone—atopic dermatitis	0.000168	0.000489	CcSEcCtD
Bosentan—Haemoglobin—Prednisone—atopic dermatitis	0.000168	0.000488	CcSEcCtD
Bosentan—Angioedema—Methylprednisolone—atopic dermatitis	0.000168	0.000488	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CCR5—atopic dermatitis	0.000167	0.00185	CbGpPWpGaD
Bosentan—Haemorrhage—Prednisone—atopic dermatitis	0.000167	0.000486	CcSEcCtD
Bosentan—Erythema—Betamethasone—atopic dermatitis	0.000167	0.000485	CcSEcCtD
Bosentan—Erythema—Dexamethasone—atopic dermatitis	0.000167	0.000485	CcSEcCtD
Bosentan—Anxiety—Hydrocortisone—atopic dermatitis	0.000166	0.000482	CcSEcCtD
Bosentan—Vertigo—Triamcinolone—atopic dermatitis	0.000165	0.000481	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000165	0.00048	CcSEcCtD
Bosentan—Syncope—Triamcinolone—atopic dermatitis	0.000165	0.00048	CcSEcCtD
Bosentan—Vertigo—Methylprednisolone—atopic dermatitis	0.000165	0.00048	CcSEcCtD
Bosentan—Syncope—Methylprednisolone—atopic dermatitis	0.000165	0.000479	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—IL5—atopic dermatitis	0.000165	0.00182	CbGpPWpGaD
Bosentan—Discomfort—Hydrocortisone—atopic dermatitis	0.000165	0.000478	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCR3—atopic dermatitis	0.000164	0.00181	CbGpPWpGaD
Bosentan—Oedema—Prednisolone—atopic dermatitis	0.000163	0.000475	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000163	0.000475	CcSEcCtD
Bosentan—Vomiting—Tacrolimus—atopic dermatitis	0.000163	0.000473	CcSEcCtD
Bosentan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000162	0.00047	CcSEcCtD
Bosentan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000162	0.000469	CcSEcCtD
Bosentan—Rash—Tacrolimus—atopic dermatitis	0.000161	0.000469	CcSEcCtD
Bosentan—Dermatitis—Tacrolimus—atopic dermatitis	0.000161	0.000468	CcSEcCtD
Bosentan—Shock—Prednisolone—atopic dermatitis	0.000161	0.000467	CcSEcCtD
Bosentan—Cough—Triamcinolone—atopic dermatitis	0.000161	0.000467	CcSEcCtD
Bosentan—Headache—Tacrolimus—atopic dermatitis	0.00016	0.000466	CcSEcCtD
Bosentan—Oedema—Hydrocortisone—atopic dermatitis	0.00016	0.000464	CcSEcCtD
Bosentan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.00016	0.000464	CcSEcCtD
Bosentan—Tachycardia—Prednisolone—atopic dermatitis	0.00016	0.000463	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—KIF3A—atopic dermatitis	0.000159	0.00176	CbGpPWpGaD
Bosentan—Infection—Hydrocortisone—atopic dermatitis	0.000159	0.000461	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000158	0.000459	CcSEcCtD
Bosentan—Shock—Hydrocortisone—atopic dermatitis	0.000157	0.000456	CcSEcCtD
Bosentan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000157	0.000455	CcSEcCtD
Bosentan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000156	0.000454	CcSEcCtD
Bosentan—Eye disorder—Prednisone—atopic dermatitis	0.000156	0.000454	CcSEcCtD
Bosentan—Anxiety—Methylprednisolone—atopic dermatitis	0.000156	0.000453	CcSEcCtD
Bosentan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000156	0.000453	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000155	0.000451	CcSEcCtD
Bosentan—Flushing—Prednisone—atopic dermatitis	0.000155	0.000451	CcSEcCtD
Bosentan—Skin disorder—Hydrocortisone—atopic dermatitis	0.000155	0.00045	CcSEcCtD
Bosentan—Discomfort—Triamcinolone—atopic dermatitis	0.000155	0.00045	CcSEcCtD
Bosentan—Discomfort—Methylprednisolone—atopic dermatitis	0.000155	0.000449	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000155	0.00171	CbGpPWpGaD
Bosentan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000154	0.000448	CcSEcCtD
Bosentan—Dry mouth—Triamcinolone—atopic dermatitis	0.000153	0.000445	CcSEcCtD
Bosentan—Angioedema—Dexamethasone—atopic dermatitis	0.000153	0.000444	CcSEcCtD
Bosentan—Angioedema—Betamethasone—atopic dermatitis	0.000153	0.000444	CcSEcCtD
Bosentan—Anorexia—Hydrocortisone—atopic dermatitis	0.000152	0.000442	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CCR5—atopic dermatitis	0.000152	0.00168	CbGpPWpGaD
Bosentan—Nausea—Tacrolimus—atopic dermatitis	0.000152	0.000442	CcSEcCtD
Bosentan—Angiopathy—Prednisone—atopic dermatitis	0.000152	0.000441	CcSEcCtD
Bosentan—Immune system disorder—Prednisone—atopic dermatitis	0.000151	0.000439	CcSEcCtD
Bosentan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00015	0.000437	CcSEcCtD
Bosentan—Oedema—Triamcinolone—atopic dermatitis	0.00015	0.000437	CcSEcCtD
Bosentan—Vertigo—Betamethasone—atopic dermatitis	0.00015	0.000436	CcSEcCtD
Bosentan—Vertigo—Dexamethasone—atopic dermatitis	0.00015	0.000436	CcSEcCtD
Bosentan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00015	0.000436	CcSEcCtD
Bosentan—Syncope—Betamethasone—atopic dermatitis	0.00015	0.000435	CcSEcCtD
Bosentan—Syncope—Dexamethasone—atopic dermatitis	0.00015	0.000435	CcSEcCtD
Bosentan—Infection—Triamcinolone—atopic dermatitis	0.000149	0.000434	CcSEcCtD
Bosentan—Hypotension—Hydrocortisone—atopic dermatitis	0.000149	0.000433	CcSEcCtD
Bosentan—Infection—Methylprednisolone—atopic dermatitis	0.000149	0.000433	CcSEcCtD
Bosentan—Shock—Triamcinolone—atopic dermatitis	0.000148	0.00043	CcSEcCtD
Bosentan—Insomnia—Prednisolone—atopic dermatitis	0.000148	0.000429	CcSEcCtD
Bosentan—Shock—Methylprednisolone—atopic dermatitis	0.000148	0.000429	CcSEcCtD
Bosentan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000147	0.000427	CcSEcCtD
Bosentan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000147	0.000427	CcSEcCtD
Bosentan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000147	0.000427	CcSEcCtD
Bosentan—Paraesthesia—Prednisolone—atopic dermatitis	0.000147	0.000426	CcSEcCtD
Bosentan—Tachycardia—Triamcinolone—atopic dermatitis	0.000147	0.000426	CcSEcCtD
Bosentan—Mental disorder—Prednisone—atopic dermatitis	0.000146	0.000425	CcSEcCtD
Bosentan—ABCB11—Metabolism—GLB1—atopic dermatitis	0.000146	0.00162	CbGpPWpGaD
Bosentan—Tachycardia—Methylprednisolone—atopic dermatitis	0.000146	0.000425	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NPS—atopic dermatitis	0.000146	0.00162	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TAC1—atopic dermatitis	0.000146	0.00162	CbGpPWpGaD
Bosentan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000146	0.000423	CcSEcCtD
Bosentan—Malnutrition—Prednisone—atopic dermatitis	0.000146	0.000423	CcSEcCtD
Bosentan—Erythema—Prednisone—atopic dermatitis	0.000146	0.000423	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000145	0.000422	CcSEcCtD
Bosentan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000145	0.000422	CcSEcCtD
Bosentan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000145	0.000421	CcSEcCtD
Bosentan—Insomnia—Hydrocortisone—atopic dermatitis	0.000144	0.000419	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCL11—atopic dermatitis	0.000144	0.00159	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CMA1—atopic dermatitis	0.000144	0.00159	CbGpPWpGaD
Bosentan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000143	0.000416	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CXCR3—atopic dermatitis	0.000143	0.00159	CbGpPWpGaD
Bosentan—Anxiety—Betamethasone—atopic dermatitis	0.000142	0.000412	CcSEcCtD
Bosentan—Anxiety—Dexamethasone—atopic dermatitis	0.000142	0.000412	CcSEcCtD
Bosentan—Discomfort—Betamethasone—atopic dermatitis	0.000141	0.000408	CcSEcCtD
Bosentan—Discomfort—Dexamethasone—atopic dermatitis	0.000141	0.000408	CcSEcCtD
Bosentan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000141	0.000408	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCL10—atopic dermatitis	0.00014	0.00155	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ADSL—atopic dermatitis	0.00014	0.00155	CbGpPWpGaD
Bosentan—Hypotension—Methylprednisolone—atopic dermatitis	0.00014	0.000407	CcSEcCtD
Bosentan—Pain—Prednisolone—atopic dermatitis	0.00014	0.000406	CcSEcCtD
Bosentan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000139	0.000403	CcSEcCtD
Bosentan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000138	0.0004	CcSEcCtD
Bosentan—Fatigue—Hydrocortisone—atopic dermatitis	0.000138	0.0004	CcSEcCtD
Bosentan—Vision blurred—Prednisone—atopic dermatitis	0.000137	0.000398	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000137	0.000398	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000137	0.000397	CcSEcCtD
Bosentan—Pain—Hydrocortisone—atopic dermatitis	0.000137	0.000397	CcSEcCtD
Bosentan—Oedema—Betamethasone—atopic dermatitis	0.000136	0.000396	CcSEcCtD
Bosentan—Oedema—Dexamethasone—atopic dermatitis	0.000136	0.000396	CcSEcCtD
Bosentan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000136	0.000396	CcSEcCtD
Bosentan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000136	0.000396	CcSEcCtD
Bosentan—Insomnia—Triamcinolone—atopic dermatitis	0.000136	0.000395	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—IL5—atopic dermatitis	0.000136	0.0015	CbGpPWpGaD
Bosentan—Insomnia—Methylprednisolone—atopic dermatitis	0.000136	0.000394	CcSEcCtD
Bosentan—Infection—Betamethasone—atopic dermatitis	0.000135	0.000394	CcSEcCtD
Bosentan—Infection—Dexamethasone—atopic dermatitis	0.000135	0.000394	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—STAT6—atopic dermatitis	0.000135	0.0015	CbGpPWpGaD
Bosentan—Paraesthesia—Triamcinolone—atopic dermatitis	0.000135	0.000392	CcSEcCtD
Bosentan—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000135	0.000391	CcSEcCtD
Bosentan—Anaemia—Prednisone—atopic dermatitis	0.000135	0.000391	CcSEcCtD
Bosentan—Shock—Betamethasone—atopic dermatitis	0.000134	0.00039	CcSEcCtD
Bosentan—Shock—Dexamethasone—atopic dermatitis	0.000134	0.00039	CcSEcCtD
Bosentan—Dyspnoea—Triamcinolone—atopic dermatitis	0.000134	0.000389	CcSEcCtD
Bosentan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000134	0.000389	CcSEcCtD
Bosentan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000134	0.000389	CcSEcCtD
Bosentan—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000134	0.000388	CcSEcCtD
Bosentan—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000134	0.000388	CcSEcCtD
Bosentan—Tachycardia—Betamethasone—atopic dermatitis	0.000133	0.000387	CcSEcCtD
Bosentan—Tachycardia—Dexamethasone—atopic dermatitis	0.000133	0.000387	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCL5—atopic dermatitis	0.000133	0.00147	CbGpPWpGaD
Bosentan—Angioedema—Prednisone—atopic dermatitis	0.000133	0.000386	CcSEcCtD
Bosentan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000132	0.000384	CcSEcCtD
Bosentan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000132	0.000383	CcSEcCtD
Bosentan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000132	0.000383	CcSEcCtD
Bosentan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000132	0.000383	CcSEcCtD
Bosentan—Vertigo—Prednisone—atopic dermatitis	0.000131	0.00038	CcSEcCtD
Bosentan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000131	0.000379	CcSEcCtD
Bosentan—Syncope—Prednisone—atopic dermatitis	0.000131	0.000379	CcSEcCtD
Bosentan—Anorexia—Betamethasone—atopic dermatitis	0.00013	0.000378	CcSEcCtD
Bosentan—Anorexia—Dexamethasone—atopic dermatitis	0.00013	0.000378	CcSEcCtD
Bosentan—Urticaria—Prednisolone—atopic dermatitis	0.00013	0.000377	CcSEcCtD
Bosentan—Fatigue—Triamcinolone—atopic dermatitis	0.00013	0.000376	CcSEcCtD
Bosentan—Fatigue—Methylprednisolone—atopic dermatitis	0.000129	0.000376	CcSEcCtD
Bosentan—Pain—Triamcinolone—atopic dermatitis	0.000129	0.000373	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—atopic dermatitis	0.000128	0.00142	CbGpPWpGaD
Bosentan—Loss of consciousness—Prednisone—atopic dermatitis	0.000128	0.000372	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000128	0.00141	CbGpPWpGaD
Bosentan—Hypotension—Dexamethasone—atopic dermatitis	0.000127	0.00037	CcSEcCtD
Bosentan—Hypotension—Betamethasone—atopic dermatitis	0.000127	0.00037	CcSEcCtD
Bosentan—Urticaria—Hydrocortisone—atopic dermatitis	0.000127	0.000368	CcSEcCtD
Bosentan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000126	0.000367	CcSEcCtD
Bosentan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000126	0.000367	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000124	0.000361	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000124	0.000361	CcSEcCtD
Bosentan—Arthralgia—Prednisone—atopic dermatitis	0.000124	0.00036	CcSEcCtD
Bosentan—Anxiety—Prednisone—atopic dermatitis	0.000123	0.000359	CcSEcCtD
Bosentan—Insomnia—Dexamethasone—atopic dermatitis	0.000123	0.000358	CcSEcCtD
Bosentan—Insomnia—Betamethasone—atopic dermatitis	0.000123	0.000358	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000123	0.000357	CcSEcCtD
Bosentan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000123	0.000356	CcSEcCtD
Bosentan—Paraesthesia—Dexamethasone—atopic dermatitis	0.000122	0.000356	CcSEcCtD
Bosentan—Paraesthesia—Betamethasone—atopic dermatitis	0.000122	0.000356	CcSEcCtD
Bosentan—Discomfort—Prednisone—atopic dermatitis	0.000122	0.000356	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCL5—atopic dermatitis	0.000121	0.00134	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisolone—atopic dermatitis	0.00012	0.00035	CcSEcCtD
Bosentan—Dyspepsia—Dexamethasone—atopic dermatitis	0.00012	0.000349	CcSEcCtD
Bosentan—Dyspepsia—Betamethasone—atopic dermatitis	0.00012	0.000349	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CCR5—atopic dermatitis	0.00012	0.00133	CbGpPWpGaD
Bosentan—Urticaria—Triamcinolone—atopic dermatitis	0.000119	0.000347	CcSEcCtD
Bosentan—Urticaria—Methylprednisolone—atopic dermatitis	0.000119	0.000346	CcSEcCtD
Bosentan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000119	0.000345	CcSEcCtD
Bosentan—Oedema—Prednisone—atopic dermatitis	0.000119	0.000345	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—atopic dermatitis	0.000119	0.000345	CcSEcCtD
Bosentan—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000119	0.000344	CcSEcCtD
Bosentan—Decreased appetite—Dexamethasone—atopic dermatitis	0.000119	0.000344	CcSEcCtD
Bosentan—Decreased appetite—Betamethasone—atopic dermatitis	0.000119	0.000344	CcSEcCtD
Bosentan—Infection—Prednisone—atopic dermatitis	0.000118	0.000343	CcSEcCtD
Bosentan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000118	0.000342	CcSEcCtD
Bosentan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000118	0.000342	CcSEcCtD
Bosentan—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000118	0.000342	CcSEcCtD
Bosentan—Fatigue—Betamethasone—atopic dermatitis	0.000118	0.000342	CcSEcCtD
Bosentan—Fatigue—Dexamethasone—atopic dermatitis	0.000118	0.000342	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CCR3—atopic dermatitis	0.000117	0.0013	CbGpPWpGaD
Bosentan—Shock—Prednisone—atopic dermatitis	0.000117	0.000339	CcSEcCtD
Bosentan—Pain—Betamethasone—atopic dermatitis	0.000117	0.000339	CcSEcCtD
Bosentan—Pain—Dexamethasone—atopic dermatitis	0.000117	0.000339	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—atopic dermatitis	0.000116	0.000338	CcSEcCtD
Bosentan—Tachycardia—Prednisone—atopic dermatitis	0.000116	0.000337	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CXCL10—atopic dermatitis	0.000116	0.00128	CbGpPWpGaD
Bosentan—Skin disorder—Prednisone—atopic dermatitis	0.000115	0.000335	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisone—atopic dermatitis	0.000115	0.000334	CcSEcCtD
Bosentan—Asthenia—Hydrocortisone—atopic dermatitis	0.000115	0.000333	CcSEcCtD
Bosentan—Anorexia—Prednisone—atopic dermatitis	0.000113	0.000329	CcSEcCtD
Bosentan—Pruritus—Hydrocortisone—atopic dermatitis	0.000113	0.000328	CcSEcCtD
Bosentan—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000112	0.000324	CcSEcCtD
Bosentan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000112	0.000324	CcSEcCtD
Bosentan—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000111	0.000322	CcSEcCtD
Bosentan—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00011	0.000321	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00011	0.00121	CbGpPWpGaD
Bosentan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000109	0.000317	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CCR5—atopic dermatitis	0.000109	0.0012	CbGpPWpGaD
Bosentan—Urticaria—Betamethasone—atopic dermatitis	0.000108	0.000315	CcSEcCtD
Bosentan—Urticaria—Dexamethasone—atopic dermatitis	0.000108	0.000315	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000108	0.000314	CcSEcCtD
Bosentan—Dizziness—Prednisolone—atopic dermatitis	0.000108	0.000314	CcSEcCtD
Bosentan—Asthenia—Triamcinolone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Abdominal pain—Betamethasone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Abdominal pain—Dexamethasone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Body temperature increased—Betamethasone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Body temperature increased—Dexamethasone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Asthenia—Methylprednisolone—atopic dermatitis	0.000108	0.000313	CcSEcCtD
Bosentan—Insomnia—Prednisone—atopic dermatitis	0.000107	0.000312	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000107	0.00118	CbGpPWpGaD
Bosentan—Paraesthesia—Prednisone—atopic dermatitis	0.000107	0.00031	CcSEcCtD
Bosentan—Pruritus—Triamcinolone—atopic dermatitis	0.000106	0.000309	CcSEcCtD
Bosentan—Pruritus—Methylprednisolone—atopic dermatitis	0.000106	0.000308	CcSEcCtD
Bosentan—Dizziness—Hydrocortisone—atopic dermatitis	0.000106	0.000307	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—TAC1—atopic dermatitis	0.000105	0.00116	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NPS—atopic dermatitis	0.000105	0.00116	CbGpPWpGaD
Bosentan—Dyspepsia—Prednisone—atopic dermatitis	0.000105	0.000304	CcSEcCtD
Bosentan—Decreased appetite—Prednisone—atopic dermatitis	0.000103	0.0003	CcSEcCtD
Bosentan—Rash—Prednisolone—atopic dermatitis	0.000103	0.000299	CcSEcCtD
Bosentan—Dermatitis—Prednisolone—atopic dermatitis	0.000103	0.000299	CcSEcCtD
Bosentan—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000103	0.000298	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CXCR3—atopic dermatitis	0.000103	0.00113	CbGpPWpGaD
Bosentan—Fatigue—Prednisone—atopic dermatitis	0.000102	0.000297	CcSEcCtD
Bosentan—Headache—Prednisolone—atopic dermatitis	0.000102	0.000297	CcSEcCtD
Bosentan—Constipation—Prednisone—atopic dermatitis	0.000102	0.000295	CcSEcCtD
Bosentan—Vomiting—Hydrocortisone—atopic dermatitis	0.000101	0.000295	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000101	0.00112	CbGpPWpGaD
Bosentan—Rash—Hydrocortisone—atopic dermatitis	0.000101	0.000292	CcSEcCtD
Bosentan—Dermatitis—Hydrocortisone—atopic dermatitis	0.000101	0.000292	CcSEcCtD
Bosentan—Headache—Hydrocortisone—atopic dermatitis	0.0001	0.000291	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCL5—atopic dermatitis	9.97e-05	0.0011	CbGpPWpGaD
Bosentan—Dizziness—Triamcinolone—atopic dermatitis	9.94e-05	0.000289	CcSEcCtD
Bosentan—Dizziness—Methylprednisolone—atopic dermatitis	9.92e-05	0.000288	CcSEcCtD
Bosentan—Asthenia—Dexamethasone—atopic dermatitis	9.78e-05	0.000284	CcSEcCtD
Bosentan—Asthenia—Betamethasone—atopic dermatitis	9.78e-05	0.000284	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—IL5—atopic dermatitis	9.72e-05	0.00108	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Prednisone—atopic dermatitis	9.71e-05	0.000282	CcSEcCtD
Bosentan—Nausea—Prednisolone—atopic dermatitis	9.71e-05	0.000282	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—IL2—atopic dermatitis	9.68e-05	0.00107	CbGpPWpGaD
Bosentan—Pruritus—Dexamethasone—atopic dermatitis	9.65e-05	0.00028	CcSEcCtD
Bosentan—Pruritus—Betamethasone—atopic dermatitis	9.65e-05	0.00028	CcSEcCtD
Bosentan—Vomiting—Triamcinolone—atopic dermatitis	9.56e-05	0.000278	CcSEcCtD
Bosentan—Vomiting—Methylprednisolone—atopic dermatitis	9.54e-05	0.000277	CcSEcCtD
Bosentan—Nausea—Hydrocortisone—atopic dermatitis	9.48e-05	0.000275	CcSEcCtD
Bosentan—Rash—Triamcinolone—atopic dermatitis	9.48e-05	0.000275	CcSEcCtD
Bosentan—Dermatitis—Triamcinolone—atopic dermatitis	9.47e-05	0.000275	CcSEcCtD
Bosentan—Rash—Methylprednisolone—atopic dermatitis	9.46e-05	0.000275	CcSEcCtD
Bosentan—Dermatitis—Methylprednisolone—atopic dermatitis	9.45e-05	0.000274	CcSEcCtD
Bosentan—Urticaria—Prednisone—atopic dermatitis	9.44e-05	0.000274	CcSEcCtD
Bosentan—Headache—Triamcinolone—atopic dermatitis	9.42e-05	0.000274	CcSEcCtD
Bosentan—Headache—Methylprednisolone—atopic dermatitis	9.39e-05	0.000273	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—atopic dermatitis	9.39e-05	0.000273	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—atopic dermatitis	9.39e-05	0.000273	CcSEcCtD
Bosentan—Diarrhoea—Dexamethasone—atopic dermatitis	9.33e-05	0.000271	CcSEcCtD
Bosentan—Diarrhoea—Betamethasone—atopic dermatitis	9.33e-05	0.000271	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NGF—atopic dermatitis	9.23e-05	0.00102	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—atopic dermatitis	9.19e-05	0.00102	CbGpPWpGaD
Bosentan—Dizziness—Dexamethasone—atopic dermatitis	9.02e-05	0.000262	CcSEcCtD
Bosentan—Dizziness—Betamethasone—atopic dermatitis	9.02e-05	0.000262	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CCR5—atopic dermatitis	8.98e-05	0.000994	CbGpPWpGaD
Bosentan—Nausea—Triamcinolone—atopic dermatitis	8.93e-05	0.000259	CcSEcCtD
Bosentan—Nausea—Methylprednisolone—atopic dermatitis	8.91e-05	0.000259	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—IL2—atopic dermatitis	8.79e-05	0.000972	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisone—atopic dermatitis	8.75e-05	0.000254	CcSEcCtD
Bosentan—Vomiting—Dexamethasone—atopic dermatitis	8.67e-05	0.000252	CcSEcCtD
Bosentan—Vomiting—Betamethasone—atopic dermatitis	8.67e-05	0.000252	CcSEcCtD
Bosentan—Rash—Betamethasone—atopic dermatitis	8.6e-05	0.00025	CcSEcCtD
Bosentan—Rash—Dexamethasone—atopic dermatitis	8.6e-05	0.00025	CcSEcCtD
Bosentan—Dermatitis—Betamethasone—atopic dermatitis	8.59e-05	0.00025	CcSEcCtD
Bosentan—Dermatitis—Dexamethasone—atopic dermatitis	8.59e-05	0.00025	CcSEcCtD
Bosentan—Headache—Dexamethasone—atopic dermatitis	8.54e-05	0.000248	CcSEcCtD
Bosentan—Headache—Betamethasone—atopic dermatitis	8.54e-05	0.000248	CcSEcCtD
Bosentan—Asthenia—Prednisone—atopic dermatitis	8.52e-05	0.000248	CcSEcCtD
Bosentan—Pruritus—Prednisone—atopic dermatitis	8.4e-05	0.000244	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—CXCL10—atopic dermatitis	8.29e-05	0.000917	CbGpPWpGaD
Bosentan—Diarrhoea—Prednisone—atopic dermatitis	8.13e-05	0.000236	CcSEcCtD
Bosentan—Nausea—Dexamethasone—atopic dermatitis	8.1e-05	0.000235	CcSEcCtD
Bosentan—Nausea—Betamethasone—atopic dermatitis	8.1e-05	0.000235	CcSEcCtD
Bosentan—Dizziness—Prednisone—atopic dermatitis	7.85e-05	0.000228	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—NFKBIA—atopic dermatitis	7.62e-05	0.000843	CbGpPWpGaD
Bosentan—Vomiting—Prednisone—atopic dermatitis	7.55e-05	0.000219	CcSEcCtD
Bosentan—Rash—Prednisone—atopic dermatitis	7.49e-05	0.000218	CcSEcCtD
Bosentan—Dermatitis—Prednisone—atopic dermatitis	7.48e-05	0.000217	CcSEcCtD
Bosentan—Headache—Prednisone—atopic dermatitis	7.44e-05	0.000216	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—atopic dermatitis	7.25e-05	0.000802	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL5—atopic dermatitis	7.14e-05	0.00079	CbGpPWpGaD
Bosentan—Nausea—Prednisone—atopic dermatitis	7.05e-05	0.000205	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—IL2—atopic dermatitis	6.92e-05	0.000766	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGF—atopic dermatitis	6.61e-05	0.000731	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—atopic dermatitis	6.58e-05	0.000728	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR5—atopic dermatitis	6.43e-05	0.000711	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL2—atopic dermatitis	6.29e-05	0.000696	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKBIA—atopic dermatitis	5.45e-05	0.000603	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—atopic dermatitis	5.43e-05	0.000601	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL2—atopic dermatitis	5.19e-05	0.000574	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—atopic dermatitis	5.16e-05	0.000572	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GLB1—atopic dermatitis	4.89e-05	0.000541	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK8—atopic dermatitis	4.78e-05	0.000529	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARA—atopic dermatitis	4.75e-05	0.000526	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ADSL—atopic dermatitis	4.69e-05	0.000518	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—atopic dermatitis	3.89e-05	0.00043	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL2—atopic dermatitis	3.71e-05	0.000411	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—atopic dermatitis	3.7e-05	0.000409	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.56e-05	0.000394	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK8—atopic dermatitis	3.42e-05	0.000378	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.22e-05	0.000357	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.09e-05	0.000342	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—atopic dermatitis	3.05e-05	0.000338	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—atopic dermatitis	2.18e-05	0.000242	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.59e-05	0.000176	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.05e-05	0.000116	CbGpPWpGaD
